1. Home
  2. GXAI vs AIMD Comparison

GXAI vs AIMD Comparison

Compare GXAI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaxos.ai Inc.

GXAI

Gaxos.ai Inc.

HOLD

Current Price

$1.07

Market Cap

12.0M

Sector

N/A

ML Signal

HOLD

Logo Ainos Inc.

AIMD

Ainos Inc.

HOLD

Current Price

$1.59

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GXAI
AIMD
Founded
2021
1984
Country
United States
United States
Employees
N/A
41
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
13.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GXAI
AIMD
Price
$1.07
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
260.2K
43.0K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
71.35
N/A
EPS
N/A
N/A
Revenue
$1,933,030.00
N/A
Revenue This Year
$271.23
N/A
Revenue Next Year
$36.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47901.74
N/A
52 Week Low
$1.02
$1.26
52 Week High
$2.96
$4.50

Technical Indicators

Market Signals
Indicator
GXAI
AIMD
Relative Strength Index (RSI) 34.56 39.45
Support Level $1.06 $1.38
Resistance Level $1.30 $1.75
Average True Range (ATR) 0.04 0.20
MACD -0.00 -0.03
Stochastic Oscillator 18.75 8.00

Price Performance

Historical Comparison
GXAI
AIMD

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: